590 material Form 8-K filings that 521 companies we cover made with the SEC in October 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On October 7, 2024, STERIS and affiliated borrowers entered a $1.1 billion revolving credit agreement with JPMorgan Chase Bank as administrative agent, replacing the credit agreement dated March 19, 2021. The facility matures five years after October 7, 2024, and proceeds will fund general corporate purposes and working capital.
Revolving facility of $1,100 million, expandable by up to $625 million at lenders' discretion
Matures five years after October 7, 2024; interest is based on a base rate or relevant rate plus an applicable margin tied to STERIS's debt rating
Contains customary covenants, including limits on leverage and a minimum interest coverage requirement
Replaces the existing credit agreement dated March 19, 2021
Murphy Oil Corporation signed a $1.2 billion senior unsecured revolving credit facility on October 7, 2024, maturing in October 2029. The same filing reports early results of its cash tender offers for senior notes, with holders tendering $258.38 million of 2027 notes, $200.15 million of 2028 notes and $62.11 million of 2029 notes by the early tender date, and the company expects to fund the early settlement on October 7 with new debt and cash on hand.
Credit agreement dated October 7, 2024 provides a $1.2 billion revolving facility maturing October 2029, with borrowings priced at SOFR- or base-rate-based rates plus an Applicable Rate.
Until the company reaches specified credit ratings, it must keep a maximum consolidated leverage ratio of 3.25x and a minimum interest coverage ratio of 2.50x.
Early tender results released October 3, 2024 show $258.38 million of 2027 notes, $200.15 million of 2028 notes and $62.11 million of 2029 notes tendered by October 2, 2024, under a $600 million cap.
The tender offers are scheduled to expire October 18, 2024, and the early settlement payment is expected on October 7, 2024, funded by a 6.000% senior notes due 2032 offering and cash on hand.
U.S. Physical Therapy's subsidiary agreed to acquire a 50% interest in MSO Metro, LLC, which manages 50 outpatient clinics, mostly in New York, and will make the company its managing member. The purchase price is approximately $76.5 million, with $75 million from cash on hand and $1.5 million in company stock, plus an earnout of up to $20.0 million if performance criteria are met. The deal is expected to close on October 31, 2024, subject to customary closing conditions.
Purchase price of approximately $76.5 million: $75 million in cash on hand and $1.5 million in common stock
Earnout of up to an additional $20.0 million if certain Metro performance criteria are achieved
Metro generates approximately $64.0 million in annual revenue and $12.0 million in annual EBITDA, per the press release
Expected closing date of October 31, 2024; the company will become managing member of Metro
PTC Inc. and a subsidiary amended their credit agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment says the springing maturity date will not occur on November 16, 2024, if PTC's Available Liquidity is at least $600 million on that date, which ties the timing of the credit facility to the company's 2025 Senior Notes due February 15, 2025.
Amendment No. 1 dated October 1, 2024 modifies the Fourth Amended and Restated Credit Agreement dated January 3, 2023.
Springing maturity would not occur on November 16, 2024, if Available Liquidity is greater than or equal to $600 million on that date.
Available Liquidity is defined as cash and Cash Equivalent Investments, readily-marketable securities, and Available Revolving Commitments.
Astec Industries named Brian J. Harris as Chief Financial Officer effective October 7, 2024. Heinrich Jonker steps down as Interim Chief Financial Officer and continues as Vice President Finance – Infrastructure Solutions. Harris previously served as CFO of Summit Materials from October 2013 to February 2023, and the filing sets his base salary at $550,000 with a long-term incentive award valued at about $800,000.
Brian J. Harris becomes CFO effective October 7, 2024; Heinrich Jonker steps down as Interim CFO.
Harris was CFO of Summit Materials from October 2013 to February 2023 and CFO of Bausch + Lomb from 2009 to 2013.
Harris's base salary is $550,000, with a target annual bonus of 70% of base salary and a long-term incentive grant valued at about $800,000, prorated for 2024.
Proto Labs disclosed a settlement agreement with Bjoern Klaas, former Vice President and General Manager of the EMEA region, who left his role in July 2024. His termination date will be November 30, 2024, and he will receive severance, bonus, and equity vesting terms. The filing describes a departure of a former officer, not a change in company leadership or financial results.
Settlement Agreement dated October 1, 2024 among Proto Labs, Proto Labs Germany GmbH and Bjoern Klaas
Termination date set for November 30, 2024
Base salary severance of EUR 299,792, equal to one times annualized base salary
Company waived Klaas' non-compete and non-solicitation obligations and will pay half of his base salary for one year
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.